ANDA 80701, held by Mutual Pharm. Prednisone.
As of Nov 14, 2026, ANDA 80701 (Prednisone), held by Mutual Pharm, was first approved by FDA on Nov 14, 1972, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 14, 1972 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisone5MG ยท tablet;oral | Prednisone | Discontinued |
| Dec 1, 1998 | Supplement 88Manufacturing | Approved | None posted |
| Apr 5, 1995 | Supplement 85Labeling | Approved | None posted |
| Jan 12, 1995 | Supplement 79Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 87Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 86Manufacturing | Approved | None posted |
| Apr 4, 1994 | Supplement 84Labeling | Approved | None posted |
| Apr 3, 1992 | Supplement 83Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 81Manufacturing | Approved | None posted |
| Apr 5, 1991 | Supplement 78Labeling | Approved | None posted |
| Apr 5, 1991 | Supplement 77Manufacturing | Approved | None posted |
| Mar 2, 1989 | Supplement 76Labeling | Approved | None posted |
| Feb 5, 1986 | Supplement 71Manufacturing | Approved | None posted |
| Nov 14, 1972 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters